A Phase 1/2 Study of INCB000928 as Monotherapy or in Combination with Ruxolitinib in Patients with Anemia Due to Myelofibrosis (INCB 00928-104). Oh, S. T., Kiladjian, J., Palandri, F., Gotlib, J. R., Mohan, S., Ali, H., Asatiani, E., Seguy, F., Zhou, F., Verstovsek, S. AMER ASSOC CANCER RESEARCH. 2021

View details for Web of Science ID 000680263501298